FMP

FMP

Enter

MAAT.PA - MaaT Pharma SA

photo-url-https://financialmodelingprep.com/image-stock/MAAT.PA.png

MaaT Pharma SA

MAAT.PA

EURONEXT

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.

7.4 EUR

-0.06 (-0.811%)

About

ceo

Mr. Herve Affagard

sector

Healthcare

industry

Biotechnology

exchange

EURONEXT

Description

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.

CIK

N/A

ISIN

FR0012634822

CUSIP

N/A

Address

70 Avenue Tony Garnier

Phone

33 4 28 29 14 00

Country

FR

Employee

54

IPO Date

Nov 8, 2021

MAAT.PA Financial Summary

CIK

-

Exchange

EURONEXT

Industry

Biotechnology

Sector

Healthcare

CUSIP

-

ISIN

FR0012634822

Country

FR

Price

7.4

Beta

0.2

Volume Avg.

1.27k

Market Cap

102.81M

Shares

-

52-Week

6.3-9.9

DCF

-5.86

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-4.35

P/B

-

Website

https://www.maatpharma.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest MAAT.PA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep